Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

J App Pharm Sci. 2023; 13(11): 32-39


Traditional Thai herbal medicine for treating COVID-19

Phayong Thepaksorn, Katanchalee Thabsri, Piyachat Evelyn Denbaes, Suwannee Sroisong, Pussadee Srathong, Suriyan Sukati.




Abstract
Cited by 0 Articles

Traditional Thai herbs, especially their phytochemicals, are believed to have a wide range of antimicrobial, anti-inflammatory, antioxidant, and antiviral properties. This review focuses on traditional Thai herbs for the potential treatment of coronavirus disease 2019 (COVID-19). Thai herbal therapies, including traditional Thai medicines, have been studied, investigated, and used to advance scientific knowledge. Specifically, Thai herbs, including Andrographis paniculata, Boesenbergia rotunda, Phyllanthus amarus, Phyllanthus emblica L., Citrus medica, Zingiber officinale, Rheum officinale Baill., and Kerra capsule, have been documented and used in the treatment of severe acute respiratory syndrome (SARS)-CoV-2. Traditional Thai herbs are believed to have various antiviral properties, and these herbs show promise as defense mechanisms against SARS-CoV-2. The focus of this review is on the traditional Thai herbs that have anti-viral properties and may have an impact on COVID-19.

Key words: Thai herbs, Kerra capsule, antiviral, COVID-19






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.